<DOC>
	<DOCNO>NCT02190539</DOCNO>
	<brief_summary>The objective study conduct feasibility study Meir Oncology Institute examine whether patient advance breast cancer would follow homeopathic protocol three six month . The primary aim study establish patient advanced breast cancer Meir Oncology Institute would follow regimen treatment use Dr Banerji India , six month . The secondary aim observe quality life wellbeing patient undergo protocol</brief_summary>
	<brief_title>Homeopathic Protocol Advanced Breast Cancer</brief_title>
	<detailed_description>- Homeopathy controversial system care center controversy lay question whether high dilution remedy effective . There handful high quality study homeopathy treatment cancer , despite widespread use condition . In recent prospective observational study do Germany cancer patient two differently treat cohort observe improvement quality life observe patient take addition homeopathic treatment . In laboratory , research homeopathy cancer exist limit clue effect ignore . A study conduct The University Texas MD Anderson Cancer Center , reveal four ultradilute remedy ( Carcinosin , Phytolacca , Conium , Thuja ) exert preferential cytotoxic effect two breast cancer cell line , cause cell cycle delay/arrest apoptosis without affect normal mammary epithelial cell . Since patient advanced breast cancer high CAM user amongst patient affected cancer , think feasibility study group patient , would rational first step proceed evaluate controversial method care , merit . - The objective study conduct feasibility study Meir Oncology Institute examine whether patient advance breast cancer would follow homeopathic protocol three six month . The primary aim study establish patient advanced breast cancer Meir Oncology Institute would follow homeopathic protocol use Dr Banerji India , six month . The secondary aim observe quality life wellbeing patient undergo protocol . - Patients diagnosis advance breast cancer attend Meir Oncology Institute clinic offer treat physician nurse fact sheet study ask participate protocol . The protocol explain patient research team . If agree participate give consent form sign , basic information obtain patient . This information include basic demographic ( age , marital status , employment , education level ) basic medical information ( Disease status progress , current symptom , medication treatment use , complementary medicine use ) well evaluation quality life use European Organization Research Treatment Cancer ( EORTC ) quality life questionnaire ( QLQ ) . - Patients receive select homeopathic remedy ( Carcinosin 30C , Phytolacca 200C , Thuja 30C ) write instruction proper use remedy . The remedy offer patient addition regular conventional care . Patients participate conventional cancer care due side effect , expect adverse reaction reason prevent utilizing conventional care offer participate study , well . In addition , patient reason elect refuse conventional treatment offer participate study order keep system lose alternative untested treatment . Every 4 week period 3 month 6 month , research assistant/ research nurse contact participant review EORTC QLQ- C-30 questionnaire evaluate quality life well follow questionnaire verify actual use remedy , perceive problem take remedy , utilization therapy , address patient concern , document disease progression . A total 30 patient enrol study data review analyzed six month recruitment study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>18 year age old Ability speak read Hebrew/English patient reside Israel . Diagnosis advance breast cancer treat follow Meir Oncology Institute Patients participate conventional cancer care due side effect , expect adverse reaction reason prevent utilizing conventional care . Patients , reason elect refuse conventional treatment , offer participate study order keep system lose alternative untested treatment . Consent participate study Inability understand intent study follow instruction Medical condition would preclude participation interview session lasting 1530 minute Diagnosis active psychosis severe cognitive impairment confirm patient 's attend physician .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>complementary medicine</keyword>
	<keyword>homeopathy</keyword>
	<keyword>quality life</keyword>
</DOC>